Insider buying surges at LifeMD—over 900k shares purchased by execs—signaling confidence amid a flat price and potential GLP‑1 growth. Explore the implications.
LifeMD insider buys signal confidence in its expanding telehealth weight‑management business and future GLP‑1 drug launches—investors should watch upcoming earnings and regulatory wins.